- NLM Digital Collections - Janus kinase inhibitors and biosimilars for rheumatoid arthritis : final policy ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, January 9, 2020Janus kinase inhibitors and biosimilars for rheumatoid arthritis : final policy recommendations ... Janus Kinase Inhibitors ... 2019 CTAF public meeting on the use of Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA). At the ...
- NLM Digital Collections - Targeted immune modulators for rheumatoid arthritis : effectiveness and value : evidence ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017Janus Kinase Inhibitors -- therapeutic use ... effects Infliximab -- therapeutic use Interleukin-6 -- antagonists & inhibitors Janus Kinase Inhibitors -- therapeutic use Randomized Controlled Trials as Topic ...
- NLM Digital Collections - Targeted immune modulators for ulcerative colitis : effectiveness and value : final evidence ....Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 16, 2020... every other week, IL: interleukin, IV: intravenous, JAK: Janus kinase, kg: kilogram, mg: milligram, q8w: every 8 weeks, ... every other week, IL: interleukin, IV: intravenous, JAK: Janus kinase, kg: kilogram, mg: milligram, q8w: every 8 weeks, ...
- NLM Digital Collections - JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis : final ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 17, 2021Janus Kinase Inhibitors ... dermatitis : final policy recommendations Antibodies, Monoclonal Dermatitis, Atopic Janus Kinase Inhibitors Following its deliberation on the evidence, the ...
- NLM Digital Collections - Assessment of COVID-19 in primary care : the identification of symptoms, signs, ...Publication: [Edinburgh, Scotland] : Scottish Intercollegiate Guidelines Network (SIGN), February 3, 2021... and conventional disease modifying drugs (with or without Janus kinase (JAK) inhibitors), non-steroidal anti-inflammatory drugs (NSAIDs) ... ratio Inflammatory bowel disease intensive care unit interleukin Janus kinase National Early Warning Score National Institute for Health ...
- NLM Digital Collections - Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis : ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 3, 2018... 25 tofacitinib and baricitinib are oral first-generation Janus kinase (JAK) inhibitors that have been shown to be ... randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate- ...
- NLM Digital Collections - Trends in retail prices of specialty prescription drugs widely used by older Americans : 2017 ...Publication: Washington, DC : AARP Public Policy Institute, June 2019... Disease-Modifying Anti-Rheumatic Drugs JAK Inhibitors JAK – Janus Kinase Antiretrovirals – NNRTI NNRTI – Non-Nucleoside Reverse Transcriptase Inhibitors ...
- NLM Digital Collections - The Molecular Genetics of Cellular OncogenesPublication: Annual Reviews, Inc., 1984... P., Steiner- Staltz, D., Berrebi, A., Aghai? B., Janus- zewicz, E. 1984. Altered ... for tyrosine protein kinases. J. Biol. Chem. 258:1108-15 Cooper, J., ...
- NLM Digital Collections - Index-catalogue of the Library of the Surgeon-General's Office, United States Army. Authors ...Publication: Washington : G.P.O., 1880-1932... 4=. Strasbourg, 1865, 2. s.. No. -69. Kien (Cornelius Janus'i. *Disp. juridica. De jure ... c. Kinases. Delezi-nne iC) Les kinases microhiennes; leuraction sur ...
- NLM Digital Collections - Index-catalogue of the Library of the Surgeon General's Office, United States Army (Series 4, ...Publication: Washington : U.S. G.P.O., 1936-1948... 232-54.—Sorrentino, B. Le disfunzioni mestruali; fisiopatologia. Kinase, ... des Schamgefiihls. Janus, Leiden, 1926, 30: 195- . 200.- Kaberry, P. M. ...
26 results